Trastuzumab and breast cancer

N Engl J Med. 2001 Sep 27;345(13):997-8.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Bone Neoplasms / drug therapy
  • Bone Neoplasms / secondary
  • Breast Neoplasms, Male / drug therapy
  • Breast Neoplasms, Male / pathology*
  • Breast Neoplasms, Male / surgery
  • Diphosphonates / therapeutic use
  • Humans
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / secondary*
  • Male
  • Middle Aged
  • Paclitaxel / therapeutic use
  • Pamidronate
  • Receptor, ErbB-2 / analysis*
  • Receptor, ErbB-2 / immunology
  • Trastuzumab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Diphosphonates
  • Receptor, ErbB-2
  • Pamidronate
  • Trastuzumab
  • Paclitaxel